AbbVie Named Official Pharmaceutical Partner of Major League Baseball
Rhea-AI Summary
AbbVie (NYSE: ABBV) announced a multi-year partnership with Major League Baseball beginning in the 2026 season to expand Striking Out Cancer league-wide. AbbVie will donate $20 per strikeout up to $1 million per season, with proceeds benefiting Stand Up To Cancer. The program launches March 25, 2026, and includes enhanced activations around marquee events and AbbVie presenting the 2026 Wild Card Series.
Positive
- Committed donation of $20 per strikeout up to $1 million per season
- League-wide activation beginning Opening Day March 25, 2026 increases national reach
- AbbVie to present the 2026 Wild Card Series, boosting visibility
Negative
- Annual donation capped at $1 million, limiting maximum charitable outlay
- Donation tied to strikeouts introduces seasonal variability in annual giving
News Market Reaction – ABBV
In the Mar 24 session, ABBV gained 0.13%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 19 | Aesthetics survey program | Positive | -1.0% | Global aesthetics survey and new AA Signature multimodal framework launch. |
| Mar 09 | Phase 1 obesity data | Positive | -1.2% | Positive topline Phase 1 multiple ascending dose results for ABBV-295. |
| Mar 04 | Aesthetics MWL data | Positive | +1.0% | Medical weight loss data showing shifting aesthetic goals and HA filler use. |
| Mar 03 | Conference participation | Neutral | -0.2% | Announcement of participation in Leerink Partners Global Healthcare Conference. |
| Mar 02 | Phase 3 Crohn’s data | Positive | +0.9% | Positive Phase 3 AFFIRM results for SKYRIZI in Crohn’s disease. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows mixed reactions to largely positive news, with several clinical and franchise updates met by modest gains or small selloffs.
Over the last month, AbbVie has released a series of mostly positive updates. These include Phase 3 Crohn’s data for SKYRIZI with strong remission and endoscopic response rates on Mar 2, and encouraging Phase 1 weight-loss results for ABBV-295 on Mar 9. Allergan Aesthetics also highlighted evolving aesthetic and weight-loss trends on Mar 4 and Mar 19. Despite favorable science and franchise positioning, price reactions ranged from about -1% to +1%, indicating that investors have treated such news as incremental rather than transformational. Today’s MLB partnership similarly fits a strategic branding narrative rather than a core earnings driver.
Key Terms
oncology medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Partnership expands "Striking Out Cancer" campaign beginning on Opening Day
- AbbVie named Official Pharmaceutical Partner of Major League Baseball (MLB), expanding Striking Out Cancer league-wide starting on Opening Day
- Each strikeout will trigger a donation from AbbVie to support Stand Up To Cancer
- Integrated across every game and key MLB events, Striking Out Cancer transforms baseball's most iconic moments into season-long national impact
Throughout the MLB season, AbbVie will donate
By uniting under a shared mission, Striking Out Cancer will become a unifying force across the league. Donations will benefit Stand Up To Cancer, a transformational organization created to raise awareness and accelerate impactful cancer research.
"Cancer impacts millions of families, and partnerships like this allow us to meet people where they are and spark meaningful conversations around awareness and action," said Tracie Haas, senior vice president, corporate affairs, AbbVie. "By expanding Striking Out Cancer across Major League Baseball, we can elevate awareness and reinforce our commitment to helping make a real difference for patients, their families and communities."
Throughout the season, Striking Out Cancer will be featured across MLB platforms, including MLB Network, MLB digital and social channels. Striking Out Cancer and its impact will also be spotlighted during some of the League's most visible moments, including the All-Star Game presented by Mastercard, MLB at Field of Dreams and the MLB Wild Card Series. The Wild Card Series will be presented by AbbVie beginning with the 2026 Postseason. With baseball's massive platform and AbbVie's leadership in oncology, Striking Out Cancer creates a rare intersection of science, sport, and story by turning strikeouts into symbols of awareness and hope.
"We're proud to partner with AbbVie and expand this important initiative across the league," said April Brown, MLB senior vice president, social responsibility. "The partnership with AbbVie exemplifies the transformative potential of sports-driven advocacy. By channeling the excitement and energy of every strikeout, the partnership delivers more than just a statistic on the field. Each "K" recorded during the season offers another opportunity in the fight against a disease that impacts the lives of so many."
"We are tremendously grateful to AbbVie for selecting Stand Up To Cancer as the beneficiary of Striking Out Cancer," said Rusty Robertson, co-founder, Stand Up To Cancer. "Collaborations like these help accelerate our mission to raise awareness and to bring new cancer treatments to patients. We are equally thankful to Major League Baseball, our founding donor, whose longstanding support has been instrumental in advancing groundbreaking cancer research. Together with the support of AbbVie and MLB, we continue to drive progress and offer hope to patients and families everywhere."
Striking Out Cancer launches on March 25th coinciding with Opening Day presented by Adobe and will continue through the MLB Postseason. For more information, please visit: www.abbvie.com/mlb.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter) and YouTube.
About AbbVie in Oncology
AbbVie is committed to elevating standards of care and bringing transformative therapies to patients worldwide living with difficult-to-treat cancers. Today, our expansive oncology portfolio is comprised of approved and investigational targeted treatments for a wide range of blood cancers and solid tumors that either impede the reproduction of cancer cells or enable their elimination. We achieve this through scientific advancements and approaches, dedicated and experienced teams and innovative partnerships that accelerate the delivery of potential breakthrough medicines. For more information, please visit www.abbvie.com/oncology.
About Major League Baseball
Major League Baseball (MLB) is the most historic professional sports league in
About Stand Up To Cancer
Stand Up To Cancer® (SU2C) raises awareness and funds research to detect and treat cancers with the aspiration to cure all patients. SU2C is a 501(c)(3) charitable organization and was initially launched as a division of the Entertainment Industry Foundation. Established in 2008 by media and entertainment leaders, SU2C utilizes these communities' resources to engage the public in supporting a new, collaborative model of cancer research, to increase awareness about cancer prevention, and to highlight progress being made in the fight against the disease. As of April 2025, more than 3,100 scientists representing more than 210 institutions are involved in SU2C-funded research projects.
The American Association for Cancer Research (AACR) is SU2C's scientific partner. A Scientific Advisory Committee, led by William G. Nelson, M.D., Ph.D., conducts rigorous competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of research progress.
Current members of the SU2C Founders and Advisors Committee (FAC) include Katie Couric, Sherry Lansing, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, and Ellen Ziffren. The late Laura Ziskin and the late Noreen Fraser are also co-founders. Julian
For more information visit StandUpToCancer.org, Instagram, TikTok, X, Facebook and YouTube.
References
- World Health Organization. Global Cancer Observatory. Published 2022. Accessed March 18, 2026. https://gco.iarc.who.int/media/globocan/factsheets/populations/900-world-fact-sheet.pdf
AbbVie Media: Gabrielle Tarbert | MLB Media: David Hochman |
View original content:https://www.prnewswire.com/news-releases/abbvie-named-official-pharmaceutical-partner-of-major-league-baseball-302723317.html
SOURCE AbbVie